Evidence map›Paper›PMID 36061230›Full record

ArticleAccreditation and quality assurance : journal for quality, comparability and reliability in chemical measurement2022

Impact of the COVID-19 pandemic on accredited conformity assessment bodies: insights from a multinational study.

Claudia Koch, Parsa Asna Ashari, Mona Mirtsch, Knut Blind, Pavel Castka

Open access · hybridAbstract read
In one paragraph

Article in Accreditation and quality assurance : journal for quality, comparability and reliability in chemical measurement, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.1field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Claudia KochS.2 Accreditation and Conformity Assessment, Bundesanstalt für Materialforschung und -prüfung (BAM), Rudower Chaussee 11, 12489 Berlin, Germany.ORCID 0000-0003-4154-0524
Parsa Asna AshariS.2 Accreditation and Conformity Assessment, Bundesanstalt für Materialforschung und -prüfung (BAM), Rudower Chaussee 11, 12489 Berlin, Germany.ORCID 0000-0002-7442-8988
Mona MirtschS.2 Accreditation and Conformity Assessment, Bundesanstalt für Materialforschung und -prüfung (BAM), Rudower Chaussee 11, 12489 Berlin, Germany.ORCID 0000-0002-2036-4579
Knut BlindTechnische Universität Berlin, Berlin, Germany.ORCID 0000-0002-6510-122X
Pavel CastkaUniversity of Canterbury, Christchurch, New Zealand.ORCID 0000-0003-1936-021X
Federal Institute For Materials Research and Testing · DEFraunhofer Institute for Systems and Innovation Research · DEUniversity of Canterbury · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic posed new and manifold challenges to organizations and their operations worldwide. Conformity assessment bodies (CABs), such as testing or medical laboratories, certification, and inspection bodies, were also affected by the associated disruptions. Their role in this crisis is highly relevant, as CABs are essential pillars of the quality infrastructure: their activities ensure that products and services meet requirements as defined in standards and regulations, thereby contributing to their safety and reliability. The question arises of how CABs and their operations were affected by the pandemic and how they responded. To this end, we present the results of an international survey of 986 CABs of all types in Germany, the UK, Italy, and New Zealand. Overall, CABs reported, on average, a reduction in demand for their services during the pandemic, facing restrictions in all countries. In addition, the pandemic had an overall negative impact on the CABs' investment and innovation activities. However, investments in digital infrastructure were increased as a countermeasure, with CABs reporting a higher need for digitalization. The paper highlights and discusses results from in-depth analyses relevant to policymakers and industry alike.

Indexed as

AccreditationConformity assessmentCOVID-19LaboratoryQuality infrastructure

Identifiers

PMID36061230
PMCPMC9423698
OpenAlexW4293493808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.